Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page adds 'Multiple myeloma' and a 'related topics' section (including MedlinePlus Genetics) to broaden disease context, and includes a new MAIA-related publication citation in the Publications list.
    Difference
    0.1%
    Check dated 2026-06-01T19:50:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.4, replacing the previous v3.5.3; this indicates a maintenance update rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-05-18T13:31:07.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new publication citation was added to the publications list, referencing a 2026 Blood Advances article on infections in patients treated with daratumumab for newly diagnosed multiple myeloma. This addition provides contextual scholarly context without altering the study’s core information.
    Difference
    0.0%
    Check dated 2026-05-11T12:14:02.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s UI/version marker was updated to **Revision: v3.5.3** and some related navigation/topic text from a prior revision was removed.
    Difference
    0.1%
    Check dated 2026-04-27T07:50:58.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a page topic and included a related topic link to MedlinePlus Genetics; updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T04:58:08.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Deleted the disease term 'Multiple Myeloma' from the page and removed the Related Topic 'MedlinePlus Genetics'. This could reduce clarity about the study's focus and remove an external educational resource, while most other study content remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-05T17:29:40.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.